Column Capital Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$40.6K Buy
2,336
+1,397
+149% +$29.1K 0.01% 346
2023
Q2
$19.6K Buy
939
+1
+0.1% +$22 ﹤0.01% 441
2023
Q1
$22.1K Buy
938
+1
+0.1% +$27 ﹤0.01% 430
2022
Q4
$26.2K Buy
937
+1
+0.1% +$26 ﹤0.01% 382
2022
Q3
$22K Buy
936
+1
+0.1% +$30 ﹤0.01% 374
2022
Q2
$32K Buy
935
+85
+10% +$2.98K 0.01% 337
2022
Q1
$30K Buy
850
+449
+112% +$15.4K 0.01% 355
2021
Q4
$12K Buy
401
+128
+47% +$4.17K ﹤0.01% 492
2021
Q3
$9K Hold
273
– – ﹤0.01% 485
2021
Q2
$8K Buy
+273
New +$8.99K ﹤0.01% 497

Other funds holding OGN

Column Capital Advisors's OGN Position: Q3 2023 in Review

Column Capital Advisors increased its Organon & Co (OGN) stake by 149% in Q3 2023, buying an estimated $29.1K and bringing the position to 2,336 shares worth $40.6K. The position accounts for 0.01% of the portfolio, ranked #346.

Column Capital Advisors first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Column Capital Advisors held 2,336 shares of Organon & Co worth $40.6K as of Q3 2023.
  • Column Capital Advisors bought 1,397 Organon & Co shares in Q3 2023, an estimated $29.1K.
  • Organon & Co made up 0.01% of Column Capital Advisors's portfolio in Q3 2023, its #346 holding.
  • Column Capital Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.